Caitong International Asset Management’s Sionna Therapeutics SION Stock Holding History

Caitong International Asset Management’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.44K	Buy	+36	New	+$1.37K	﹤0.01%	1317

Other funds holding SION

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caitong International Asset Management's SION Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Sionna Therapeutics (SION) in Q1 2026: 36 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #1317 among its holdings.

122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

Caitong International Asset Management held 36 shares of Sionna Therapeutics worth $1.44K as of Q1 2026.
Sionna Therapeutics was a new Caitong International Asset Management position in Q1 2026.
Sionna Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1317 holding.
122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.